Spots Global Cancer Trial Database for TRACE: Tirapazamine-Radiation And Cisplatin Evaluation
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: TRACE: Tirapazamine-Radiation And Cisplatin Evaluation
Official Title: Phase III Randomized Trial of Concomitant Radiation, Cisplatin, and Tirapazamine Versus Concomitant Radiation and Cisplatin in Patients With Advanced Head and Neck Cancer
Study ID: NCT00174837
Conditions
Study Description
Brief Summary: The trial will compare the efficacy and safety of concomitant chemoradiation with tirapazamine, cisplatin and radiation versus cisplatin and radiation.
Detailed Description:
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Sanofi-Aventis Administrative Office, Bridgewater, New Jersey, United States
Sanofi-Aventis Administrative Office, Buenos Aires, , Argentina
Sanofi-Aventis Administrative Office, Cove, , Australia
Sanofi-Aventis Administrative Office, Laval, , Canada
Sanofi-Aventis Administrative Office, Santiago, , Chile
Sanofi-Aventis Administrative Office, Paris, , France
Sanofi-Aventis Administrative Office, Berlin, , Germany
Sanofi-Aventis Administrative Office, Causeway Bay, , Hong Kong
Sanofi-Aventis Administrative Office, Budapest, , Hungary
Sanofi-Aventis Administrative Office, Milan, , Italy
sanofi-aventis New Zealand administrative office, Macquarie Park, , New Zealand
Sanofi-Aventis Administrative Office, Warszawa, , Poland
Sanofi-Aventis Administrative Office, Singapore, , Singapore
Sanofi-Aventis Administrative Office, Midrand, , South Africa
Sanofi-Aventis Administrative Office, Barcelona, , Spain
Sanofi-Aventis Administrative Office, Geneva, , Switzerland
Sanofi-Aventis Administrative Office, Taipei, , Taiwan
Contact Details
Name: ICD CSD
Affiliation: Sanofi
Role: STUDY_DIRECTOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
